Uveitis screening

Jump to navigation Jump to search

Uveitis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Uveitis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Uveitis screening On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Uveitis screening

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Uveitis screening

CDC on Uveitis screening

Uveitis screening in the news

Blogs on Uveitis screening

Directions to Hospitals Treating Uveitis

Risk calculators and risk factors for Uveitis screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Tarek Nafee, M.D. [2]

Overview

Screening

There is insufficient evidence to recommend routine screening for uveitis for the general population. For patients diagnosed with systematic conditions strongly associated with uveitis, there are guidelines for screening for uveitis in asymptomatic patients. This includes: Juvenile idiopathic arthritis Based on Cinncinati Children's Hospital BESt evidence guidelines, screening for uveitis in children with JIA is recommended as follows: It is recommended that a referral for an initial screening examination for uveitis be made by the rheumatology provider upon diagnosis of JIA, and the exam be performed within one month after diagnosis of JIA. It is recommended that after the initial screening examination, regular follow-up screenings be maintained based on risk category and classification. For access to the complete guideline, click here

Sarcoidosis

References

Template:WH Template:WS